In this article, we will discuss the 10 Best Forever Stocks to Buy According to Analysts.
Rising expectations of the US Federal Reserve hiking interest rates is sending shockwaves through Wall Street. That was evident as the tech-heavy Nasdaq 100 tumbled by about 4% after a much stronger-than-expected US jobs report for May triggered bets of a Fed hike.
“The market was overbought and sentiment was euphoric. May non-farm payrolls were the straw to break the camel’s back,” said Mike Zigmont at Visdom Investment Group.
Amid the healthy correction, Wall Street strategists remain optimistic about the market’s long-term outlook. Morgan Stanley strategists, led by Mike Wilson, insist the S&P 500 has what it takes to hit 8,000 by year-end, backed by upward earnings revisions and supportive macro data.
“Markets rarely move in a straight line at the pace seen since the March lows,” he wrote in a research note published Monday. “A correction was inevitable and ultimately healthy if this bull market is going to extend into year-end.”
Citigroup strategists led by Scott Chronert have also raised their S&P 500 target to $8,100 from $7,700, buoyed by a strong earnings season. On its part, Bank of America warns that the elevated Wall Street optimism has reached a level historically associated with sharp market pullbacks. However, the investment bank insists the current mood is more bullish but not euphoric.
TaLaNoVa/Shutterstock.com
Our Methodology
To compile a list of the Best Forever Stocks to Buy According to Analysts, we focused on companies that stay steady and keep growing, making them good picks for people who want to invest for the long run. We analyzed ETFs and compilations that listed blue-chip, high-quality, and wide-moat companies. From that sample, we selected the stocks most favored by elite hedge funds in Q1 2026 and showing positive upside potential (as of June 7). We ranked the stocks in ascending order based on their hedge fund holdings.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research shows we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).
Best Forever Stocks to Buy According to Analysts
10. Tesla, Inc. (NASDAQ:TSLA)
Stock Upside Potential: 3.46%
Number of Hedge Fund Holders: 123
Tesla, Inc. (NASDAQ:TSLA) is one of the best forever stocks to buy, according to analysts. On June 7, JPMorgan reiterated that Tesla (NASDAQ:TSLA)’s ambitions around autonomous vehicles, humanoid robotics, and energy storage are underappreciated. Consequently, the investment bank upgraded the stock to Neutral from Underweight.
JPMorgan expects Tesla’s share price to rise to about $475 a share from the prior $145 estimate by December 2027. The upgrade and share price target increase center on Tesla’s vertical integration across hardware and software, which remains unmatched at an industrial scale.
According to JPMorgan analysts, continued use of Tesla’s factory for testing of robots, including Optimus humanoid, offers a competitive edge in validating the product for broader commercial sale. In addition, the move is expected to lower manufacturing costs.
JPMorgan also remains bullish on the company’s robotaxi service, which launched in Austin last year and has since been expanded to Dallas, Houston, and the Bay Area. The investment bank sees significant network effect advantages for Tesla in attaining over 10 billion FSD miles and 9 million autonomous vehicles on the road.
Tesla, Inc. (NASDAQ:TSLA) designs, manufactures, and sells electric vehicles, renewable energy generation and storage systems, and advanced AI and robotics. Its primary mission is to accelerate the world’s transition to sustainable energy.
9. Eli Lilly and Company (NYSE:LLY)
Stock Upside Potential: 36.73%
Number of Hedge Fund Holders: 132
Eli Lilly and Company (NYSE:LLY) is one of the best forever stocks to buy, according to analysts. On June 7, Eli Lilly and Company (NYSE:LLY) announced top-line results for Foundayo (orforglipron), the only oral GLP-1 that can be taken without food or water restrictions.
Clinical trial results showed that women with obesity and who were overweight experienced significant weight loss at the average stage of menopause on taking the highest dose of Foundayo. The candidate drug was associated with significant weight reduction at 72 weeks across various menopausal stages.
In ATTAIN 1, women in premenopausal taking Foundayo lost up to 14.4% of weight, and those in post-menopause lost up to 14.1%. In ATTAIN-2, women taking Foundayo lost significant weight despite struggling with type 2 diabetes. The trial results affirm that Foundayo is an effective weight loss remedy in women at every stage of menopause. The positive clinical trial results are a welcome given that Menopause is a major yet often overlooked driver of weight gain.
Eli Lilly and Company (NYSE:LLY) is a global healthcare and pharmaceutical leader that discovers, develops, and manufactures innovative medicines. It is well known for its blockbuster treatments for diabetes (such as Mounjaro), chronic weight management (such as Zepbound), oncology, immunology, and neurodegeneration.
